1847205

ISO 16256:2012

Clinical laboratory testing and in vitro diagnostic test systems - Reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases

standard by International Organization for Standardization , 12/01/2012

This document has been replaced. View the most recent version.

View all product details

Historical

Track It

Language:
    • Available Formats
    • Options
    • Availability
    • Priced From ( in USD )
    • Printed Edition
    • Ships in 1-2 business days
    • $128.00
    • Add to Cart
    • Printed Edition + PDF
    • Immediate download
    • $183.00
    • Add to Cart

Customers Who Bought This Also Bought

Identical Versions Available

 

About This Item

 

Full Description

ISO 16256:2012 describes a method for testing the susceptibility to antifungal agents of yeasts, including Candida spp. and Cryptococcus neoformans, that cause infections. The reference method described here has not been used in studies of the yeast forms of dimorphic fungi, such as B. dermatitidis and/or H. capsulatum variety capsulatum.

ISO 16256:2012 describes the broth microdilution reference method which can be implemented by either of two pathways. One pathway involves visual determination of MICs (CLSI method); the second pathway involves spectrophotometric determination of MICs (EUCAST method).

 

Product Details

Published:
12/01/2012
File Size:
1 file , 440 KB
Same As:
BS EN ISO 16256:2012, DIN EN ISO 16256, BS EN ISO 16256:2012
Note:
This product is unavailable in Ukraine, Russia, Belarus
 

Document History

  1. ISO 16256:2021


    Clinical laboratory testing and in vitro diagnostic test systems - Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases

    • Most Recent

  2. ISO 16256:2012

    👀 currently
    viewing


    Clinical laboratory testing and in vitro diagnostic test systems - Reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases

    • Historical Version